Jan 9, 2026 04:51AM
Nov 6, 2025 08:00AM
Oct 28, 2025 06:42AM
Oct 20, 2025 09:23AM
Oct 20, 2025 08:00AM
Oct 20, 2025 08:00AM
Sep 29, 2025 04:38PM Rapt Therapeutics (RAPT) PT Raised to $41 at Clear Street
Sep 29, 2025 05:45AM
Sep 29, 2025 05:00AM
Jul 10, 2025 06:42AM
Nov 12, 2024 04:08PM
Nov 12, 2024 04:04PM
Nov 11, 2024 11:45AM
Nov 11, 2024 08:04AM RAPT Therapeutics (RAPT): Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury
Nov 11, 2024 08:00AM
Aug 8, 2024 08:00AM
May 9, 2024 04:03PM
May 9, 2024 08:00AM
Apr 9, 2024 12:00PM
Apr 9, 2024 12:00PM
Mar 11, 2024 09:00PM RAPT ALERT: Bragar Eagel & Squire, P.C. is Investigating RAPT Therapeutics, Inc. on Behalf of RAPT Stockholders and Encourages Investors to Contact the Firm
Mar 7, 2024 08:00AM
Feb 21, 2024 06:43AM
Feb 21, 2024 04:02AM
Feb 20, 2024 10:46AM
Feb 20, 2024 07:30AM
Feb 20, 2024 07:30AM
Nov 3, 2023 12:00PM RAPT Therapeutics Announces Positive Data, Including Objective Response Rates and Progression-Free Survival, from its Phase 2 Trial of FLX475 in Combination with a Checkpoint Inhibitor in Patients wit
May 25, 2023 05:00PM
May 3, 2023 08:00AM
Mar 29, 2023 08:01AM
Mar 29, 2023 08:00AM
Mar 29, 2023 08:00AM

322,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All